Literature DB >> 27002318

Understanding the Patient Perspective of Seizure Severity in Epilepsy: Development of a Conceptual Model.

Simon Borghs1, Erin L Tomaszewski2, Katarina Halling3, Christine de la Loge4.   

Abstract

PURPOSE: For patients with uncontrolled epilepsy, the severity and postictal sequelae of seizures might be more impactful than their frequency. Seizure severity is often assessed using patient-reported outcome (PRO) instruments; however, evidence of content validity for existing instruments is lacking. Our aim was to understand the real-life experiences of patients with uncontrolled epilepsy.
METHODS: A preliminary conceptual model was developed. The model was refined through (1) a targeted literature review of qualitative research on seizure severity; (2) interviews with four clinical epilepsy experts to evaluate identified concepts; and (3) qualitative interviews with patients with uncontrolled epilepsy, gathering descriptions of symptoms and impacts of epilepsy, focusing on how patients experience and describe "seizure severity." Findings were summarized in a final conceptual model of seizure severity in epilepsy.
RESULTS: Twenty-five patients (12 who experienced primary generalized tonic-clonic seizures and 13 who experienced partial-onset seizures) expressed 42 different symptoms and 26 different impacts related to seizures. The final conceptual model contained a wide range of concepts related to seizure frequency, symptoms, and duration.
CONCLUSION: Our model identified several new concepts that characterize the patient experience of seizure severity. A seizure severity PRO instrument should cover a wide range of seizure symptoms alongside frequency and duration of seizures. This qualitative work reinforces the notion that measuring seizure frequency is insufficient and that seizure severity is important in defining the patient's experience of epilepsy. This model could be used to assess the content validity of existing PRO instruments, or could support the development of a new one.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27002318     DOI: 10.1007/s40271-016-0165-0

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  53 in total

1.  The Cambridge Depersonalization Scale: a new instrument for the measurement of depersonalization.

Authors:  M Sierra; G E Berrios
Journal:  Psychiatry Res       Date:  2000-03-06       Impact factor: 3.222

2.  Development of the Health and Work Questionnaire (HWQ): an instrument for assessing workplace productivity in relation to worker health.

Authors:  Richard Shikiar; Michael T Halpern; Anne M Rentz; Zeba M Khan
Journal:  Work       Date:  2004

3.  Patient-validated content of epilepsy-specific quality-of-life measurement.

Authors:  F Gilliam; R Kuzniecky; E Faught; L Black; G Carpenter; R Schrodt
Journal:  Epilepsia       Date:  1997-02       Impact factor: 5.864

Review 4.  Qualitative research and its methods in epilepsy: Contributing to an understanding of patients' lived experiences of the disease.

Authors:  Frances Rapport; Clare Clement; Marcus A Doel; Hayley A Hutchings
Journal:  Epilepsy Behav       Date:  2015-04-03       Impact factor: 2.937

5.  A method of quantification for the evaluation of antiepileptic drug therapy.

Authors:  J A Cramer; D B Smith; R H Mattson; A V Delgado Escueta; J F Collins
Journal:  Neurology       Date:  1983-03       Impact factor: 9.910

Review 6.  Neuropsychological effects of epilepsy and antiepileptic drugs.

Authors:  P Kwan; M J Brodie
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

7.  The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale.

Authors:  M F O'Donoghue; J S Duncan; J W Sander
Journal:  Epilepsia       Date:  1996-06       Impact factor: 5.864

8.  Development of the quality of life in epilepsy inventory.

Authors:  O Devinsky; B G Vickrey; J Cramer; K Perrine; B Hermann; K Meador; R D Hays
Journal:  Epilepsia       Date:  1995-11       Impact factor: 5.864

9.  The Chalfont Seizure Severity Scale.

Authors:  J S Duncan; J W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

10.  Sensitivity testing of the Seizure Severity Questionnaire (SSQ).

Authors:  Simon Borghs; Christine de la Loge; Yves Brabant; Joyce Cramer
Journal:  Epilepsy Behav       Date:  2013-11-22       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.